SCHEMBL102469

SCHEMBL102469

O=[C]c1cccc(Cl)c1[C]=O

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.36
CYP2A6 P11509 2/20 0.36
ALDH1A1 P00352 3/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
TSHR P16473 3/20 0.35
LMNA P02545 1/20 0.35
KCNH2 Q12809 1/20 0.34
DYRK1A Q13627 1/20 0.33
KDM4E B2RXH2 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
GRM5 P41594 1/20 0.32
HTR3E A5X5Y0 1/20 0.31
HTR3B O95264 1/20 0.31
HTR3A P46098 1/20 0.31
HTR3D Q70Z44 1/20 0.31
HTR3C Q8WXA8 1/20 0.31
AKR1B1 P15121 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL96213 0.85 CYP1A2 (0.43) CYP1A2CYP2A6ALDH1A1MEN1KMT2A
SCHEMBL1965147 0.82 CYP3A4 (0.33)
SCHEMBL95210 0.78 TSHR (0.42) CYP1A2CYP2A6ALDH1A1MEN1KMT2A
SCHEMBL10624786 0.78 MAPK1 (0.31) TDP1
SCHEMBL97421 0.77
SCHEMBL7920276 0.75 CYP3A4 (0.30)
SCHEMBL2045854 0.74 IDO1 (0.37) CYP1A2CYP2A6ALDH1A1MEN1KMT2A
SCHEMBL2053018 0.74 ALDH1A1 (0.46) CYP1A2CYP2A6ALDH1A1MEN1KMT2A
SCHEMBL7358839 0.74 CYP1A2 (0.59) CYP1A2CYP2A6ALDH1A1MEN1KMT2A
SCHEMBL8098754 0.74 CYP1A2 (0.35) CYP1A2CYP2A6ALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104039867-B Polyetherimide, its preparation method and the product being formed by it 沙特基础全球技术有限公司 2017-03-01 CN claimed
CN-103958569-B polyetherimides, methods of manufacture, and articles formed therefrom 沙特基础全球技术有限公司 2016-09-21 CN claimed
US-6355615-B1 CYCLIC POLYAMIDEESTER COPOLYMERS BAYER AKTIENGESELLSCHAFT (DE) 2002-03-12 US claimed
EP-0986549-A1 DESOXYCYCLODEPSIPEPTIDES AND THEIR USE FOR COMBATTING ENDOPARASITES Bayer Aktiengesellschaft (DE) 2000-03-22 EP claimed
WO-1998055469-A1 DESOXYCYCLODEPSIPEPTIDES AND THEIR USE FOR COMBATTING ENDOPARASITES BAYER AKTIENGESELLSCHAFT (DE) 1998-12-10 WO claimed
US-20170283478-A1 PROCESS FOR PREPARATION OF LIRAGLUTIDE DR. REDDY'S LABORATORIES LIMITED (IN) 2017-10-05 US disclosed
CN-104039867-B Polyetherimide, its preparation method and the product being formed by it 沙特基础全球技术有限公司 2017-03-01 CN disclosed
CN-103958569-B polyetherimides, methods of manufacture, and articles formed therefrom 沙特基础全球技术有限公司 2016-09-21 CN disclosed
WO-2016005960-A1 PROCESS FOR PREPARATION OF LIRAGLUTIDE DR. REDDY'S LABORATORIES LIMITED (IN) 2016-01-14 WO disclosed
EP-2426102-A1 PROCESS FOR PRODUCING PHTHALIC ACID COMPOUND INCLUDING CHLORINATED AROMATIC RING Sumitomo Chemical Company, Limited (JP) 2012-03-07 EP disclosed
US-20120035395-A1 PROCESS FOR PRODUCING PHTHALIC ACID COMPOUND INCLUDING CHLORINATED AROMATIC RING SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-02-09 US disclosed
US-6355615-B1 CYCLIC POLYAMIDEESTER COPOLYMERS BAYER AKTIENGESELLSCHAFT (DE) 2002-03-12 US disclosed
EP-0986549-A1 DESOXYCYCLODEPSIPEPTIDES AND THEIR USE FOR COMBATTING ENDOPARASITES Bayer Aktiengesellschaft (DE) 2000-03-22 EP disclosed
WO-1998055469-A1 DESOXYCYCLODEPSIPEPTIDES AND THEIR USE FOR COMBATTING ENDOPARASITES BAYER AKTIENGESELLSCHAFT (DE) 1998-12-10 WO disclosed
US-4169150-A MUSCLE RELAXANTS, HYPNOSIS, ANTICONVULSANTS, SEDATIVES TEIJIN LIMITED (JP) 1979-09-25 US disclosed
US-4138553-A 3-Methylene cephalosporanic acid derivatives and process for preparation thereof TEIJIN LIMITED (JP) 1979-02-06 US disclosed
US-3936478-A Process for the preparation of desmosterol derivatives TEIJIN LIMITED (JA) 1976-02-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120035395-A1 PROCESS FOR PRODUCING PHTHALIC ACID COMPOUND INCLUDING CHLORINATED AROMATIC RING NISCH, DDT, CUL1 CYP1A2 1254/4885CYP2A6 152/4885ALDH1A1 2049/4885
US-20170283478-A1 PROCESS FOR PREPARATION OF LIRAGLUTIDE GLP1R, IAPP, GCG CYP1A2 2093/4885CYP2A6 1460/4885ALDH1A1 4728/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.